Immunotherapy - PDFSEARCH.IO - Document Search Engine

Immunotherapy
Results: 985

#	Item
481	Update on Immunotherapy Trials for HIV and Cancer Protocol #[removed]: CD4-zeta CAR T in HIV Patients Protocol #[removed]: MAGE A3 TCR for Myeloma Protocol #[removed]: MAGE A3 TCR for Melanoma Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-30 15:18:55 Anatomy Immunology Chimeric antigen receptor HIV/AIDS T helper cell CD4 Immunotherapy Peripheral blood mononuclear cell Lymphocyte Immune system T cells Biology
482	FDA Briefing Document Oncologic Drugs Advisory Committee Meeting May 2, 2013 NDA[removed] – 001 Melblez Kit Delcath Systems, Inc. Add to Reading List Source URL: www.fda.gov Language: English Delcath Systems Inc. Hepatocellular carcinoma Uveal melanoma Ipilimumab Immunotherapy End point of clinical trials DecisionDx-UM Sunitinib Medicine Hepatology Melanoma
483	Microsoft Word - Indication and Important Safety Information for PROVENGE.docx Add to Reading List Source URL: dendreon.com Language: English - Date: 2012-08-19 21:46:13 Sipuleucel-T Immunotherapy Prostate cancer Medicine Dendreon Cancer vaccines
484	ESMO Preceptorship on Immuno Oncology 2014 Add to Reading List Source URL: www.esmo.org Language: English Stahel Medicine Immunology Immunotherapy
485	Recombinant DNA Advisory Committee Meeting June 8-9, 2004 Discussion of Human Gene Transfer Protocol #[removed]entitled: A phase I open label, non-randomized, dose-escalation, multi-center, therapeutic trial of the safet Add to Reading List Source URL: webconferences.com Language: English - Date: 2004-06-08 13:20:22 Immunology Ras subfamily Carcinogenesis Immunotherapy Medicine Oncology KRAS
486	GCC-Targeted Immunotherapy Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-13 12:04:32 Adjuvant therapy Cancer immunotherapy Colorectal cancer Cancer staging Tumor antigen Chemotherapy Management of cancer Cancer Neoadjuvant therapy Medicine Cancer treatments Immunotherapy
487	ID-LV305: A LENTIVECTOR THERAPEUTIC CANCER VACCINE SAFETY BY DESIGN DECEMBER 05, 2013 Breakthrough Therapeutic Vaccines © Immune Design Corp. The information contained herein is subject to copyright Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-04-28 15:05:04 Anatomy Immunotherapy Cancer immunotherapy DC-SIGN Dendritic cell T cell Medicine Biology Immunology
488	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting September 12, 2012 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-11-26 15:13:35 Stem cells Cancer treatments Acute leukemia Myeloid leukemia Hematopoietic stem cell transplantation Minimal residual disease Acute myeloid leukemia Immunotherapy Myelodysplastic syndrome Medicine Biology Transplantation medicine
489	RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting June 19, 2012 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-11-26 15:17:35 Cancer treatments Cytokines T cells Gene delivery Gene therapy Chimeric antigen receptor Immunotherapy Cell culture Recombinant DNA Biology Medicine Biotechnology
490	Present The Damon Runyon Cancer Research Foundation Clinical Investigator Symposium Monday, April 27, 2009 Add to Reading List Source URL: www.damonrunyon.org Language: English - Date: 2013-08-07 07:09:37 Cancer research Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance Targeted therapy Prostate cancer Immunotherapy Indiana University School of Medicine Tata Memorial Centre Medicine Oncology Cancer organizations

UPDATE